INTRASTRIATAL INFUSIONS OF BRAIN-DERIVED NEUROTROPHIC FACTOR - RETROGRADE TRANSPORT AND COLOCALIZATION WITH DOPAMINE-CONTAINING SUBSTANTIA-NIGRA NEURONS IN RAT
Ej. Mufson et al., INTRASTRIATAL INFUSIONS OF BRAIN-DERIVED NEUROTROPHIC FACTOR - RETROGRADE TRANSPORT AND COLOCALIZATION WITH DOPAMINE-CONTAINING SUBSTANTIA-NIGRA NEURONS IN RAT, Experimental neurology, 129(1), 1994, pp. 15-26
The pattern of retrogradely transported BDNF, a member of the nerve gr
owth family of neurotrophins, following intrastriatal infusion was imm
unohistochemically visualized within the rodent central nervous system
. Human recombinant BDNF was infused at a rate of 3 mu g/h for 7 days
with an Alzet 2002 minipump prior to sacrifice. Tissue immunohistochem
ically processed using a turkey anti-BDNF antibody revealed retrograde
ly transported BDNF within neurons located mainly within the ipsilater
al frontoparietal cortex (predominantly layer V), parafascicular and p
osterior thalamic nuclei, and substantia nigra, pars compacta. Section
s dual immunoreacted for BDNF and tyrosine hydroxylase revealed a subp
opulation of dopaminergic neurons (approximately 28%) within the pars
compacta which contained retrogradely transported BDNF. Experiments in
which a mixture of BDNF and the retrograde tracer fluorogold were sim
ultaneously infused for 7 days into the striatum revealed BDNF and flu
orogold single-labeled neurons as well as BDNF and fluorogold dual-lab
eled cells within the substantia nigra, pars compacta. These observati
ons indicate that only a subpopulation of neurons within the substanti
a nigra retrogradely transport BDNF following intrastriatal infusion a
nd thus only a subpopulation of cells may be responsive to the trophic
influences of BDNF. The retrograde transport of trophins, such as BDN
F, represents a unique neuroanatomical tool to selectivity map the loc
ation of specific neurotrophin-responsive systems. Unraveling the trop
hic anatomy of BDNF will aid in understanding its role in development,
degeneration, and experimental animal models of regeneration providin
g essential data for its use in clinical neurodegenerative disorders i
ncluding Parkinson's disease. (C) 1994 Academic Press, Inc.